NFKB1 and diabetic kidney disease: In rats, EA exerted anti-inflammatory and antioxidant functions against streptozotocin -induced diabetic nephropathy via reducing the activation of NF-κB and increasing the nuclear translocation of Nrf2 to up-regulate the activities of GSH, γ-GCL and SOD [18].